LIQUDCA Trademark

Trademark Overview

On Friday, January 6, 2017, a trademark application was filed for LIQUDCA with the United States Patent and Trademark Office. The USPTO has given the LIQUDCA trademark a serial number of 87291844. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 17, 2020. This trademark is owned by Retrophin, Inc.. The LIQUDCA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation for the treatment of liver disease
liqudca

General Information

Serial Number87291844
Word MarkLIQUDCA
Filing DateFriday, January 6, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2017

Trademark Statements

Goods and Servicespharmaceutical preparation for the treatment of liver disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRetrophin, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameRetrophin, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, February 18, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 17, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2019EXTENSION 4 GRANTED
Wednesday, July 10, 2019EXTENSION 4 FILED
Wednesday, July 10, 2019TEAS EXTENSION RECEIVED
Tuesday, November 20, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 20, 2018EXTENSION 3 GRANTED
Tuesday, November 20, 2018EXTENSION 3 FILED
Tuesday, November 20, 2018TEAS EXTENSION RECEIVED
Wednesday, May 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 21, 2018EXTENSION 2 GRANTED
Monday, May 21, 2018EXTENSION 2 FILED
Monday, May 21, 2018TEAS EXTENSION RECEIVED
Monday, May 21, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2017EXTENSION 1 GRANTED
Monday, November 13, 2017EXTENSION 1 FILED
Monday, November 13, 2017TEAS EXTENSION RECEIVED
Monday, November 13, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 11, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 30, 2017ASSIGNED TO EXAMINER
Friday, January 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 10, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

liqudca disease liver treatment preparation pharmaceutical